학술논문
LBA28 A randomised double-blind placebo-controlled phase II trial of palbociclib combined with letrozole (L) in patients (pts) with oestrogen receptor-positive (ER+) advanced/recurrent endometrial cancer (EC): NSGO-PALEO / ENGOT-EN3 trial
Document Type
Abstract
Author
Source
In Annals of Oncology September 2020 31 Supplement 4:S1160-S1160
Subject
Language
ISSN
0923-7534